AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Washington Highlights > March 28, 2003

MedPAC Prepares June Report

March 28, 2003 - At its March 20-21 meeting, the Medicare Payment Advisory Commission (MedPAC) discussed issues to be incorporated into its June 2003 Report to Congress. The issues included, among others, the payment method for outpatient drugs, the growth in the volume of physician services, and using quality incentives in the Medicare program.

The MedPAC staff presentation on the payment method for outpatient drugs noted that the annual growth rate for outpatient drugs has been more than 20 percent for the past three years. There are several problems with the current system, including:

  • Payments based on the average wholesale price (AWP) overstate provider acquisition costs;
  • The payment system can lead to higher prices; and
  • High drug prices may be used to subsidize payments for drug administration.

MedPAC staff noted that the only way to capture the other expenses associated with administrating outpatient drugs is through a complete revision of the practice expense relative value units (RVUs), which would affect other specialties. The Commissioners' discussion focused on how to implement a new payment methodology. Additional information and a formal recommendation will be presented at the Commission's April meeting.

Commissioners also heard a presentation on the growth in the volume of physician services. The MedPAC staff presentation focused on whether "defensive medicine" in states with high professional liability insurance premiums contributed to the increased volume. The evidence presented was inconclusive. Commissioners will discuss this issue further at the April meeting. They will also review additional research and a formal recommendation on this topic at that time.

The Commission initially examined the issue of quality incentives in Medicare in September 2002. The MedPAC staff presentation examined the use of quality incentives in private markets and the potential applicability in Medicare. Commissioners discussed whether incentives should be provider based (bonuses) or beneficiary based (lower premiums). MedPAC staff will present a formal recommendation based on the Commissioners discussion at the April meeting.

Information:
Richard Chard, Senior Research Associate
AAMC Health Care Affairs
rchard@aamc.org
(202) 862-6297

Jeff Patyk, Staff Specialist
AAMC Health Care Affairs
jpatyk@aamc.org
(202) 828-0498

e-mail icon Get Washington Highlights in your Inbox!

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement